Lumida
/VCYT
⌘K
Veracyte Inc

Veracyte Inc

VCYT
$40.87USD-2.76%-1.16 today

MARKET CAP

3.4B

P/E (TTM)

37.8x

FWD P/E

DAY RANGE

$41 – $43

52W RANGE

$29
$61

AI Summary

Stalk
Sell NowMedium

VCYT is currently in a distribution phase with price forming sequential lower highs and lower lows under declining EMAs. The medium-term bias is Bearish with supply dominating demand, and short-term timing confirms bearish execution now on rallies into the 9/20 EMA zone. Execution should be Sell Now, as no pullback exhaustion is evident. Key risk is a mean-reversion bounce that holds above dynamic EMAs, invalidating the downtrend.

  • Q2 ’26 revenue $150.3M, +15% YoY driven by Decipher and Affirma demand
  • Full-year revenue guidance raised to $590–$596M, reflecting strong pipeline performance
  • Negative earnings yield indicates potential overvaluation and deters value investors
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$219.5M$296.5M$361.1M$445.8M$517.1M
YoY %+86.8%+35.1%+21.8%+23.5%+16.0%
P / Sales12.7x5.5x5.5x6.9x6.6x
EV / Sales12.4x5.2x5.1x6.7x6.0x
Gross Profit, Adj.$145.1M$175.7M$229.7M$298.1M$362.5M
YoY %+90.9%+21.1%+30.7%+29.8%+21.6%
Margin %66.1%59.2%63.6%66.9%70.1%
EV / Gross Profit18.7x8.8x8.0x10.0x8.6x
EBITDA, Adj.$-62.3M$-11.8M$9.7M$43.0M$99.7M
YoY %-127.0%+81.0%+182.3%+341.1%+132.0%
Margin %-28.4%-4.0%2.7%9.6%19.3%
EV / EBITDA-43.6x-130.8x189.4x69.4x31.4x
EBIT$-81.9M$-41.1M$-85.8M$16.1M$57.8M
YoY %-131.4%+49.8%-108.8%+118.8%+257.9%
Margin %-37.3%-13.9%-23.8%3.6%11.2%
EV / EBIT-33.2x-37.7x-21.5x184.6x54.1x
Net Income$-75.6M$-36.6M$-74.4M$24.1M$66.4M
YoY %-116.5%+51.6%-103.5%+132.4%+174.9%
Net Margin-34.4%-12.3%-20.6%5.4%12.8%
EPS (GAAP)-$1.11-$0.51-$1.02$0.31$0.82
YoY %-68.2%+54.1%-100.0%+130.4%+164.5%